Welcome to LookChem.com Sign In|Join Free
  • or
3-Bromo-5-fluoro-4-pyridinecarboxylic acid is a chemical compound characterized by the molecular formula C6H3BrFNO2. It is a derivative of pyridinecarboxylic acid, distinguished by the presence of both bromine and fluorine atoms within its structure. 3-Bromo-5-fluoro-4-pyridinecarboxylic acid is recognized for its unique structural features, which render it a valuable intermediate in the synthesis of a variety of biologically active compounds.

955372-86-8

Post Buying Request

955372-86-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

955372-86-8 Usage

Uses

Used in Pharmaceutical Industry:
3-Bromo-5-fluoro-4-pyridinecarboxylic acid is utilized as a key building block in the synthesis of various pharmaceuticals. Its incorporation into the molecular structures of drugs enhances their biological activity and therapeutic potential, making it an essential component in the development of new medications.
Used in Agrochemical Production:
In the agrochemical sector, 3-Bromo-5-fluoro-4-pyridinecarboxylic acid serves as an intermediate for the creation of compounds with pesticidal or herbicidal properties. Its unique chemical characteristics contribute to the effectiveness of these agrochemicals in controlling pests and weeds, thereby supporting agricultural productivity.
Used in Fine Chemicals Synthesis:
3-Bromo-5-fluoro-4-pyridinecarboxylic acid is also employed in the synthesis of fine chemicals, which are high-purity chemicals used in various specialized applications. Its role in this context is to provide specific functional groups or structural elements that are crucial for the performance of these high-value chemicals.
Used in Medicinal Chemistry Research and Drug Discovery:
3-Bromo-5-fluoro-4-pyridinecarboxylic acid is an important tool in the field of medicinal chemistry and drug discovery. Its unique properties make it suitable for exploring new chemical spaces and for the design of novel therapeutic agents. Researchers leverage 3-Bromo-5-fluoro-4-pyridinecarboxylic acid to investigate its potential interactions with biological targets, contributing to the advancement of pharmaceutical science.

Check Digit Verification of cas no

The CAS Registry Mumber 955372-86-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,5,3,7 and 2 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 955372-86:
(8*9)+(7*5)+(6*5)+(5*3)+(4*7)+(3*2)+(2*8)+(1*6)=208
208 % 10 = 8
So 955372-86-8 is a valid CAS Registry Number.

955372-86-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-bromo-5-fluoropyridine-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 3-BROMO-5-FLUORO-4-PYRIDINECARBOXYLIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:955372-86-8 SDS

955372-86-8Relevant academic research and scientific papers

OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

-

, (2019/09/30)

The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.

OXADIAZOLONES AS TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

-

Paragraph 0202-0205, (2018/06/12)

The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.

NOVEL HETEROARYL-SUBSTITUTED ARYLAMINOPYRIDINE DERIVATIVES AS MEK INHIBITORS

-

Page/Page column 32; 67-68, (2008/06/13)

The invention provides novel heteroaryl-substituted arylaminopyridine derivative MEK inhibitors of Formula (Ia) Formula (Ia) Such compounds are MEK inhibitors that are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation. Also disclosed is the treatment of a hyperproliferative disease in mammals, and pharmaceutical compositions containing such compounds

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 955372-86-8